CH 26: Hypertension Flashcards

(40 cards)

1
Q

homeostasis resulting from increased blood pressure in the cardiovascular system

A

vasodilation
decreased stroke volume
decreased HR
decreased CO
blood pressure back to normal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

homeostasis resulting from increased blood pressure in the kidneys

A

increased urine output
decreased blood volume
blood pressure returns to normal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

primary HTN

A

no identifiable cause

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

secondary HTN caused by:

A

 Diseases: for example, Cushing’s, hyperthyroid, CKD
 Drugs: corticosteroids, contraceptives, alcohol, amphetamines,
caffeine, decongestants,
Many times there are no symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

4 organs most affected by prolonged HTN or uncontrolled HTN

A

 Heart
 Brain
 Kidneys
 Retina

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

consequences of HTN

A

 Heart must work harder
o Excessive workload can ultimately cause heart to fail = heart
failure (HF)
 Damage to the blood vessels
o Can result in transient ischemic attacks and strokes
 Damage to the arteries of the kidneys
o Can result in CKD
 Damage to the vessels in the retina
o Can result in rupture or occlusion = visual impairment and
blindness
 If HTN continues, damage to the organs and tissues can be irreversible

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

lifestyle recommendations for HTN

A

 Limit intake of alcohol.
 Restrict sodium consumption and increase potassium intake.
 Reduce intake of saturated fat and cholesterol and increase
consumption of fresh fruits and vegetables.
 Increase physical activity.
 Discontinue use of tobacco products.
 Reduce sources of stress and learn to implement coping strategies.
 Maintain optimal weight.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

goal of pharmacotherapy for HTN

A

reduce morbidity and mortality

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Alpha2 Agonists action

A

Decrease SNS impulses to heart and arterioles = vasodilation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Alpha 1 Blockers action

A

inhibit SNS action on arterioles = vasodilation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

direct vasodilators

A

Act on smooth muscle of arterioles = vasodilation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

calcium channel blockers

A

Block calcium ion channels in arteries causing vasodilation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Angiotensin receptor blockers

A

Prevent angiotensin II from reaching the receptors = vasodilation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

ACE inhibitors (angiotensin-converting enzyme)

A

Block formation of angiotensin II = vasodilation AND block aldosterone secretion = decrease fluid volume

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

diuretics

A

Increase urine output = decrease fluid volume

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Beta blockers

A

Decrease heart rate and myocardial contractility = reduce CO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

treatment begins at systolic greater than 120 with:

A

non-pharmacologic changes

18
Q

drug treatment starts with systolic greater than

19
Q

therapeutic effects of lisinopril (ACE inhibitors)

A

Block formation of angiotensin II = vasodilation AND block
aldosterone secretion = decrease fluid volume

19
Q

adverse effects of lisinopril (ACE inhibitors)

A

Headache,
dizziness,
orthostatic hypotension,
rash,
cough
Angioedema,
acute renal failure,
first-dose phenomenon,
fetal toxicity,
hyperkalemia

20
Q

monitoring for lisinopril (ACE INHIBITORS)

A

Persistant cough
Postural hypotension– first dose phenomenon
Hyperkalemia with potassium sparing diurectics
Monitor labs for glucose,
eletrolytes, AST, ALT, BUN, creatinine
Potassium!

21
Q

safety for lisinopril (ACE inhibitors)

A

angioedema - emergency!
No use during pregnancy
NSAIDs can reduce the effect
Alcohol may increase hypotension
Can lead to lithium toxicity

22
Q

adverse effects of losartan (ARBs)

A

Headache,
dizziness,
orthostatic
hypotension,
diarrhea,
fatigue,
upper respiratory tract infection
Angioedema,
acute renal
failure,
first-dose phenomenon,
fetal toxicity,
hyperkalemia,
nephrotoxicity
(aliskiren)

23
Q

safety and monitoring for losartan (ARBs)

A

Hypoglycemia
UTIs
anemia
Dizziness and fainting after first couple of doses
Fetal injury and death when taken with pregnancy

24
therapeutic effects of nifedipine (selective CCB) and diltiazem (non-selective CCB)
Block calcium ion channels in arteries causing vasodilation Nifedipine: decrease HTN and angina
25
adverse effects of nifedipine (selective CCB) and diltiazem (non-selective CCB)
Flushed skin, headache, dizziness, peripheral edema, lightheadedness, nausea, constipation, fatigue, sexual dysfunction Hepatotoxicity, MI, HF, confusion, mood changes, angioedema
26
safety and monitoring of nifedipine (selective CCB) and diltiazem (non-selective CCB)
monitor for digoxin toxicity do not crush or divide alcohol increases vasodilation and can lead to syncope
27
therapeutic effects of atenolol (beta blocker)
Decrease heart rate and myocardial contractility = reduce cardiac output Reduced blood pressure Reduce angina Heart failure, MI Migraines
28
adverse effects of atenolol (beta blocker)
Fatigue, insomnia, drowsiness, impotence or decreased libido, bradycardia, confusion Agranulocytosis, laryngospasm, Stevens-Johnson syndrome, anaphylaxis; if the drug is abruptly withdrawn, palpitations, rebound HTN, dysrhythmias, MI
29
safety and monitoring for atenolol (beta blocker)
Broncho-constriction Fatigue and intolerance Caution in patients with asthma or HF Do not stop abruptly! Can result in rebound hypertension and MI
30
therapeutic effects of doxazosin (alpha 1 - alpha blockers)
Inhibit SNS activation in arterioles = vasodilation Lower blood pressure Bph symptoms
31
adverse effects of doxazosin (alpha 1 - alpha blockers)
Orthostatic hypotension, dizziness, headache, fatigue First-dose phenomenon, tachycardia, dyspnea
32
safety and monitoring of doxazosin (alpha 1 - alpha blockers)
Orthostatic hypotension HYPOTENSION Sedation and dizziness Hemolytic anemia, leukopenia, thrombo- cytopenia, lupus. Caution with erectile dysfunction drug = low bp NSAIDs can decrease effect
33
therapeutic effects of clonidine (alpha 2 adrenergic blockers)
Decrease SNS impulses to heart and arterioles = vasodilation
34
adverse effects of clonidine (alpha 2 adrenergic blockers)
Peripheral edema, sedation, depression, headache, dry mouth, decreased libido Hepatotoxicity, hemolytic anemia, granulocytopenia
35
therapeutic effects of hydralazine (direct acting vasodilators)
Act on the smooth muscle of arterioles = vasodilation Not first choice due to side effects
36
adverse effects of hydralazine (direct acting vasodilators)
Orthostatic hypotension, fluid retention, headache, palpitations Lupus-like reaction (hydralazine), severe hypotension, MI, dysrhythmias, shock
37
safety and monitoring of hydralazine (direct acting vasodilators)
Reflex tachycardia** Sodium and water retention Can develop tolerance over time DO NOT STOP ABRUPTLY Severe hypotension with other anti-hypertensives
38
swelling around the lips, eyes, throat, and other body regions.
angioedema
39
compensatory response to the sudden decrease in blood pressure caused by the drug.
reflex tachycardia